Literature DB >> 974413

The effect of pulmonary metabolites of prostaglandins E1, E2 and F2alpha on ADP-induced aggregation of human and rabbit platelets [proceedings].

J Westwick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974413      PMCID: PMC1667334     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  5 in total

1.  THE AGGREGATION OF BLOOD PLATELETS.

Authors:  G V BORN; M J CROSS
Journal:  J Physiol       Date:  1963-08       Impact factor: 5.182

2.  Determination of ATP and ADP in blood platelets: a modification of the firefly luciferase assay for plasma.

Authors:  H Holmsen; E Storm; H J Day
Journal:  Anal Biochem       Date:  1972-04       Impact factor: 3.365

3.  Potent bronchoconstrictor activity of 15-keto prostaglandin F2alpha.

Authors:  W Dawson; R L Lewis; R E McMahon; W J Sweatman
Journal:  Nature       Date:  1974-07-26       Impact factor: 49.962

4.  Relationship between chemical structure and platelet-aggregation activity of prostaglandins.

Authors:  J Kloeze
Journal:  Biochim Biophys Acta       Date:  1969-10-28

5.  The biological activities of three metabolites of prostaglandin E 1.

Authors:  E Anggård
Journal:  Acta Physiol Scand       Date:  1966-04
  5 in total
  5 in total

1.  Formation of biologically active 13,14-dihydro-prostaglandin E1 during intravenous infusion of prostaglandin E1 in newborns with ductus arteriosus-dependent congenital heart disease.

Authors:  A Leonhardt; H Schweer; D Wolf; H W Seyberth
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

Review 2.  Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs.

Authors:  Melissa Gabbs; Shan Leng; Jessay G Devassy; Md Monirujjaman; Harold M Aukema
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

3.  Prostaglandins and model aspects of thrombosis.

Authors:  J Westwick
Journal:  Postgrad Med J       Date:  1977-11       Impact factor: 2.401

4.  Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects.

Authors:  W Cawello; H Schweer; R Müller; R Bonn; H W Seyberth
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

5.  Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.

Authors:  M J Parry
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.